Vaxart, Inc.
VXRT· OTC
Filed Nov 2, 2011 · 10-Q · 39 days after period end · 0001193125-11-292989
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $1.09M | $12.34M |
| Net Income | $78.00K | $5.14M |
| EPS Diluted | -$0.07 | $0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Sep 24, 2011 · filed Nov 2, 2011 · 39 d after period end